Sertraline Hydrochloride Capsule
Product Images NDC 70771-1913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 70771-1913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E5ff2f30 1085 40b7 A090 A8393a7c422f 01)

FDA Label Image

Label (E5ff2f30 1085 40b7 A090 A8393a7c422f 02)

Label (E5ff2f30 1085 40b7 A090 A8393a7c422f 02)
This is a description of a medication packaging for Sertraline Hydrochloride Capsules with details such as the dosage, storage instructions, and manufacturer information. The package includes 30 capsules and a Medication Guide for patients. It contains 168mg of sertraline hydrochloride which is equivalent to 160mg of sertraline. Recommended dosage information is provided in the accompanying prescribing information. The packaging is child-resistant, and it should be kept out of reach of children. The medication should be stored between 20°C to 25°C, with allowed excursions between 15°C and 30°C. The manufacturer is Zydus Pharmaceuticals Ltd.*
FDA Label Image

Label (E5ff2f30 1085 40b7 A090 A8393a7c422f 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.